Director George Tidmarsh resigns from Revelation Biosciences board to avoid conflict of interest

REVELATION BIOSCIENCES, INC.

George Tidmarsh, MD, PhD resigned from the Board on May 23, 2025, to avoid conflict with new US governmental agency work.
Board size reduced from 5 to 4; Lakhmir Chawla, MD reclassified as Class C Director.
Resignation was not due to any disagreement with the company's operations, policies, or practices.
Tidmarsh served as a Class C Director for 5 years; term was set to expire at the 2025 Annual Meeting.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

George Tidmarsh

Director

REVB · REVELATION BIOSCIENCES, INC.

Effective: 2025-05-23
Filed: May 28, 2025, 7:59 PM ET

On May 23, 2025, George Tidmarsh, M.D., Ph.D., resigned from the Board of Directors of Revelation Biosciences, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

George Tidmarsh resigned as Director at REVELATION BIOSCIENCES, INC..

Action: resigned
Role: Director

Exact text from the filing

On May 23, 2025, George Tidmarsh, M.D., Ph.D., resigned from the Board of Directors of Revelation Biosciences, Inc. (the “Company”).

View on SEC.gov

REVELATION BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0000950170-25-078340

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.